Aspen Pharmacare Holdings Limited

Johannesburg Stock Exchange APN.JO

Aspen Pharmacare Holdings Limited EBITDA for the year ending June 30, 2024: USD 544.90 M

Aspen Pharmacare Holdings Limited EBITDA is USD 544.90 M for the year ending June 30, 2024, a 8.42% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Aspen Pharmacare Holdings Limited EBITDA for the year ending June 30, 2023 was USD 502.60 M, a -21.41% change year over year.
  • Aspen Pharmacare Holdings Limited EBITDA for the year ending June 30, 2022 was USD 639.52 M, a 6.02% change year over year.
  • Aspen Pharmacare Holdings Limited EBITDA for the year ending June 30, 2021 was USD 603.22 M, a 45.10% change year over year.
  • Aspen Pharmacare Holdings Limited EBITDA for the year ending June 30, 2020 was USD 415.73 M, a 6.21% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
Johannesburg Stock Exchange: APN.JO

Aspen Pharmacare Holdings Limited

CEO Mr. Stephen Bradley Saad BCom, CA(SA)
IPO Date Jan. 4, 2000
Location South Africa
Headquarters Aspen Place
Employees 8,867
Sector Health Care
Industries
Description

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.

Similar companies

WHL.JO

Woolworths Holdings Limited

USD 3.12

0.15%

SHP.JO

Shoprite Holdings Limited

USD 15.24

0.21%

MTN.JO

MTN Group Limited

USD 5.14

11.37%

FSR.JO

FirstRand Limited

USD 3.89

0.87%

SOL.JO

Sasol Limited

USD 5.03

-1.74%

StockViz Staff

January 15, 2025

Any question? Send us an email